VANDA PHARMACEUTICALS INC (VNDA)

US9216591084 - Common Stock

4.47  +0.09 (+2.05%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
192.64M254.40M268.70M248.20M227.20M
Cost Of Goods
14.80M24.30M25.60M23.40M24.50M
Gross Profit
177.84M230.10M243.10M224.80M202.70M
Operating Expenses
191.80M223.80M181.10M190.60M179.90M
Research and Development
76.82M85.80M55.60M48.70M48.60M
Selling, General, and Administrative Expenses
112.88M136.50M124.00M140.50M129.70M
Operating Income
-13.95M6.30M62.00M34.10M22.80M
Other Income/Expense
20.29M5.00M200.00K4.40M6.20M
Non Recurring Items
N/AN/A-19.80M-6.90MN/A
Income Before Taxes
6.34M11.30M42.40M31.70M29.00M
Income Tax
3.83M5.00M9.20M8.30M-86.50M
Net Income
2.51M6.30M33.20M23.30M115.60M
EBITDA
-10.94M9.00M64.90M37.00M25.70M
 
Per Share Data
EPS Diluted Total Ops
0.040.110.580.422.11
Non GAAP EPS
0.050.120.580.430.50
 
Statistics
Gross Profit Margin
92.32%90.45%90.47%90.57%89.22%
Profit Margin
1.30%2.48%12.36%9.39%50.88%
Operating Profit Margin
-7.24%2.48%23.07%13.74%10.04%

All data in USD

Charts